Diabetes Care Devices Market Estimated Growth Analysis During 2017- 2023Posted by Sandeep Salunkhe on March 13th, 2019 Diabetes care devices are used to test the blood glucose level in a patient’s body. These devices are also used to deliver insulin to the body of a diabetic patient. The global diabetes care devices market was valued at ,867 million in 2016, and is expected to reach ,208 million by 2023, growing at a CAGR of 5.8% from 2017 to 2023. The major factor that contributes to the growth of the market include the increase in incidence rate of diabetes caused by rapid urbanization and sedentary lifestyle. Moreover, technological advancements in the field of diabetes devices, rise in obese population, consumption of junk food, and surge in need for faster and safer diagnosis and treatment of diabetes further boost the market growth. Download Sample @ https://www.alliedmarketresearch.com/request-sample/2842 However, blood glucose monitoring devices do not measure the exact level of glucose in blood and give a range in which the blood glucose level of a patient may lie. In addition, adverse effects associated with some of the diabetes care devices also hinder the market growth. Rise in awareness about diabetes monitoring devices and untapped market opportunities in the developing regions are expected to provide numerous opportunities for the market growth. Key Findings of the Diabetes Care Devices Market:
North America accounted for more than two-fifths share of the global market in 2016, and is expected to remain dominant throughout the forecast period. This is attributed to the increase in incidence of diabetes, growth in geriatric population, and adoption of sedentary lifestyle of people that leads to diabetes. In addition, high adoption rate of technologically advanced devices and presence of highly sophisticated healthcare infrastructure are expected to present new growth opportunities to the players in this market. The major companies profiled in the report include Abbott Laboratories, ACON Laboratories, Inc., Ascensia Diabetes Care Holdings AG (formerly diabetes case business of Bayer AG), Becton, Dickinson and Company, Dexcom, Inc., F. Hoffmann-La Roche Ltd, Johnson & Johnson, Medtronic plc, Novo Nordisk A/S, and Terumo Corporation. Send Enquiry Us @ https://www.alliedmarketresearch.com/purchase-enquiry/2842 Like it? Share it!More by this author |